NICE TAs

28/08/2025

TA1093: Idebenone for treating visual impairment in Leber's hereditary optic neuropathy in people 12 years and over

28/08/2025

TA1095: Guselkumab for previously treated moderately to severely active Crohn's disease

28/08/2025

TA1094: Guselkumab for treating moderately to severely active ulcerative colitis

27/08/2025

TA1092: Pembrolizumab with carboplatin and paclitaxel for untreated primary advanced or recurrent endometrial cancer

26/08/2025

TA1028: Bimekizumab for treating moderate to severe hidradenitis suppurativa (terminated appraisal)

20/08/2025

TA1091: Tarlatamab for extensive-stage small-cell lung cancer after 2 or more treatments

19/08/2025

TA1090: Durvalumab with tremelimumab for untreated advanced or unresectable hepatocellular carcinoma

13/08/2025

TA1088: Ruxolitinib cream for treating non-segmental vitiligo in people 12 years and over

06/08/2025

TA1086: Ribociclib with an aromatase inhibitor for adjuvant treatment of hormone receptor-positive HER2-negative early breast cancer at high risk of recurrence

06/08/2025

TA1087: Betula verrucosa for treating moderate to severe allergic rhinitis or conjunctivitis caused by tree pollen

30/07/2025

TA1085: Vanzacaftor-tezacaftor-deutivacaftor for treating cystic fibrosis with 1 or more F508del mutations in the CFTR gene in people 6 years and over

23/07/2025

TA1079: Fruquintinib for previously treated metastatic colorectal cancer

14/07/2025

TA752: Belimumab for treating active autoantibody-positive systemic lupus erythematosus

10/07/2025

TA1081: Zanubrutinib for treating relapsed or refractory mantle cell lymphoma

10/07/2025

TA1080: Mirikizumab for treating moderately to severely active Crohn's disease

02/07/2025

TA1076: Adagrasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer (terminated appraisal)

02/07/2025

TA1077: Nemolizumab for treating moderate to severe atopic dermatitis in people 12 years and over

02/07/2025

TA1075: Dapagliflozin for treating chronic kidney disease

25/06/2025

TA1078: Fosdenopterin for treating molybdenum cofactor deficiency type A

25/06/2025

TA1074: Sparsentan for treating primary IgA nephropathy